Literature DB >> 21956411

Clinical review: Ethical and medical considerations of androgen deprivation treatment of sex offenders.

Louis J Gooren1.   

Abstract

CONTEXT: Blood testosterone codetermines the threshold for erotosexual imagery and sexual activity. Androgen deprivation may therefore have a place in the treatment of unacceptable sexual behavior. Although androgen deprivation can be effective for sex offenders, their basic human rights must be respected; otherwise such treatment constitutes a violation of their physical integrity and is ethically unacceptable. As experience in treating prostate cancers demonstrates, androgen deprivation may have serious side effects. Endocrinologists are qualified to advise on and monitor androgen deprivation, but they are placed in an atypical position because the indication for such treatment is not dictated by endocrine disease.
OBJECTIVE: The aim of this study was to provide an ethical framework for advising on androgen deprivation treatment of sex offenders and dealing with side effects. EVIDENCE ACQUISITION AND SYNTHESIS: A literature search was conducted in PubMed, Psychinfo, and references from the multiple systematic reviews and meta-analyses published on this topic. An attempt has been made to provide an appreciation of the ethical aspects of androgen deprivation in sex offenders, the efficacy of treatment, the potential risks of treatment, therapeutic options, and recommendations for monitoring treatment.
CONCLUSIONS: Provided that the human rights of sex offenders are respected and informed consent is given, androgen deprivation within a comprehensive framework of psychotherapeutic treatment can make a meaningful contribution to the prevention of recidivism by enabling better control of sexual impulses. Knowledge of side effects and their treatment has been mostly gleaned from experience with prostate cancer patients, and this should be made available to sex offenders undergoing androgen deprivation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21956411     DOI: 10.1210/jc.2011-1540

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

Review 1.  Pharmacological interventions for those who have sexually offended or are at risk of offending.

Authors:  Omer Khan; Michael Ferriter; Nick Huband; Melanie J Powney; Jane A Dennis; Conor Duggan
Journal:  Cochrane Database Syst Rev       Date:  2015-02-18

2.  Chemical castration for sexual offenders: physicians' views.

Authors:  Joo Yong Lee; Kang Su Cho
Journal:  J Korean Med Sci       Date:  2013-01-29       Impact factor: 2.153

Review 3.  If I could just stop loving you: anti-love biotechnology and the ethics of a chemical breakup.

Authors:  Brian D Earp; Olga A Wudarczyk; Anders Sandberg; Julian Savulescu
Journal:  Am J Bioeth       Date:  2013       Impact factor: 11.229

4.  Brave New Love: The Threat of High-Tech "Conversion" Therapy and the Bio-Oppression of Sexual Minorities.

Authors:  Brian D Earp; Anders Sandberg; Julian Savulescu
Journal:  AJOB Neurosci       Date:  2014-01

Review 5.  Testosterone deficiency: a historical perspective.

Authors:  Eberhard Nieschlag; Susan Nieschlag
Journal:  Asian J Androl       Date:  2014 Mar-Apr       Impact factor: 3.285

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.